
    
      Insulin signaling in the brain is associated with improved cognitive function in both animal
      and human studies. Intranasal administration of insulin, which is non-invasive and minimizes
      the risk of hypoglycemia, may represent a new intervention approach with the potential to
      improve cognition and real life functioning in this patient with schizophrenia.
    
  